Speragen
Speragen, Inc. is a biopharmaceutical company based in Austin, TX, specializing in the development of innovative treatments for rare disorders. With a focus on Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD), Speragen aims to provide hope and support to patients and families affected by this often underdiagnosed disorder. Through a partnership with GC Pharma, Speragen is working on the development of an enzyme replacement therapy (ERT) and launching a newborn screening program for early identification of SSADHD patients.
GC Pharma, formerly known as Green Cross Corporation, is a global biopharmaceutical company headquartered in Yongin, South Korea. With a strong commitment to quality healthcare solutions, GC Pharma has been a leader in the production of plasma protein therapeutics and vaccines for over 50 years. Through their collaboration with Speragen, GC Pharma brings their expertise in ERT development and manufacturing to advance the treatment options for SSADHD, addressing the unmet needs of patients worldwide.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
